Purpose of Review <p>To review current available risk scores for pericarditis risk stratification.</p> Recent Findings <p>Four recent published scores have provided new clinical tools for the evaluation of risk of recurrent pericarditis after a first episode or acute pericarditis (Athens score) or complicated pericarditis (Torino score), diagnosis of pericarditis (pericarditis INFLA-score) or clinical remission (Cleveland Clinic/ Klein score).</p> Summary <p>Recent scores for pericarditis diagnosis or risk stratification have been developed by tertiary referral centres with the aim of improving risk stratification and diagnosis and allowing an individualized approach for treatment and follow-up identifying the high-risk group of patients. While these scores are helpful in developing a more evidence-based approach for risk stratification of pericarditis, they have some limitations (single-centre, tertiary centres with referral bias, relatively limited sample size, new therapies not always included) and require further validation before clinical implementation in large unselected populations.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Scores for Risk Stratification of Pericarditis

  • Massimo Imazio,
  • Alessandro Andreis,
  • Allan Klein,
  • George Lazaros,
  • Emilia Lazarou,
  • Valentino Collini

摘要

Purpose of Review

To review current available risk scores for pericarditis risk stratification.

Recent Findings

Four recent published scores have provided new clinical tools for the evaluation of risk of recurrent pericarditis after a first episode or acute pericarditis (Athens score) or complicated pericarditis (Torino score), diagnosis of pericarditis (pericarditis INFLA-score) or clinical remission (Cleveland Clinic/ Klein score).

Summary

Recent scores for pericarditis diagnosis or risk stratification have been developed by tertiary referral centres with the aim of improving risk stratification and diagnosis and allowing an individualized approach for treatment and follow-up identifying the high-risk group of patients. While these scores are helpful in developing a more evidence-based approach for risk stratification of pericarditis, they have some limitations (single-centre, tertiary centres with referral bias, relatively limited sample size, new therapies not always included) and require further validation before clinical implementation in large unselected populations.